Epigenetic-based diagnostic test for early detection of cerebrovascular disease and stroke risk. Developed in collaboration with Beijing Tiantan Hospital, this test supports stroke prevention initiatives. The product integrates findings from a large-scale stroke cohort study.
Manufactured by
China
BioChain (Beijing) Science & Technology Inc. is a pioneer in cancer early diagnosis and screening in China. The company specializes in developing NGS and PCR-based cancer gene methylation detection products, focusing on early cancer diagnosis reagent kits and large-scale laboratory screening platforms.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GenSure Biotech Inc.
China · 2 relevant products
Rapid Technology LLC
Russia · 3 relevant products
ABCDx
Spain · 5 relevant products
ADmit Therapeutics SL
Spain · 2 relevant products
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 4 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 8 relevant products
Shanghai Chemtron Biotech Co.,Ltd.
China · 1 relevant product
Fujirebio Diagnostics,Inc.
China · 1 relevant product
Lansion Biotechnology Co., Ltd.
China · 1 relevant product
Weihai Kangzhou Biotechnology Engineering Co.,Ltd
China · 1 relevant product
39 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 75 closest product alternatives
GenSure Biotech Inc. · China
Diagnostic test kit for measurement of biomarkers associated with cerebrovascular disease and stroke risk. Facilitates assessment of neurological and cerebrovascular health status.
Rapid Technology LLC · Russia
Point-of-care diagnostic test for detecting ischemic stroke and traumatic brain injury based on biomarkers.
ABCDx · Spain
A rapid biochemical test that differentiates between ischemic stroke and intracranial hemorrhage within the first 4 hours from symptom onset. The test uses a combination of biomarkers to provide accurate diagnosis for stroke subtype determination, enabling rapid decision-making at point-of-care settings including ambulances and primary hospitals. This allows for timely initiation of specific treatment protocols such as reperfusion therapies.
Rapid Technology LLC · Russia
Rapid diagnostic test for identification of acute ischemic stroke using biomarker analysis.
ADmit Therapeutics SL · Spain
An early detection diagnostic test designed for clinical practice to identify Alzheimer's disease at preliminary stages. The test utilizes proprietary technology to support early diagnosis and patient management in clinical settings.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Molecular genetic test for identifying cardiovascular disease risk factors and drug response markers. Enables personalized treatment strategies for heart disease management.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A DNA methylation-based molecular diagnostic test designed for early detection and risk assessment across multiple cancer types. The test utilizes proprietary methylation technology to identify cancer signals in biological samples.
Shanghai Chemtron Biotech Co.,Ltd. · China
A diagnostic test designed to assess cardiovascular health and detect markers associated with heart disease and related conditions.
ABCDx · Spain
Rapid diagnostic test for detecting large vessel occlusion in acute ischemic stroke patients using brain biomarkers. Enables fast clinical validation and patient stratification to guide immediate intervention decisions in stroke management.
Rapid Technology LLC · Russia
Rapid diagnostic test for assessment of traumatic brain injury using key biomarkers.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A specialized DNA methylation-based test for early detection and diagnosis of colorectal cancer. The test provides risk stratification and early screening capabilities for colorectal malignancies.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Molecular diagnostic kit for genetic testing and variant detection. Supports precision medicine applications in cardiovascular and oncology disease management.
63 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products